Widely used type 2 diabetes medication metformin may be combined with antihypertensive drug syrosingopine to help fight cancer, reported a recent study. The drug cocktail that had adverse impact on the key functions of mitochondria destroyed tumor cells that require abundant energy for growth and metabolic activities.
Medicine December 31, 2016
A new review finds no significant difference among type 2 diabetes patients who take antidiabetic drugs and their rates of cardiovascular and all-cause mortality. Findings support the official advice that metformin is a good initial disease treatment.
Medicine July 20, 2016
The battle against diabetes continues, as a major trial in Scotland aims to prevent type 1 diabetes in children. Researchers will test an alternative theory to prevent the disease's development using metformin, a type 2 diabetes drug.
Life April 20, 2016
Researchers find that the common diabetes drug metformin can lower the death risk from cancers among postmenopausal women who also have type 2 diabetes. Experts caution that more research is needed to determine the drug's exact role in the association.
Life April 19, 2016
Metformin may help reduce cancer death risk, a new study has found. The old diabetes drug may then have the potential to be a valuable drug for patients with both cancer and diabetes.
Life April 16, 2016
A new study highlighted the potential benefit of key diabetes treatment metformin in helping diabetic patients recover from a heart attack. Heart disease remains the leading illness in this patient group, accounting for more than half of fatalities.
Life February 10, 2016
Researchers from the group T1D Exchange discovered that obese or overweight teenagers with type 1 diabetes may not receive the same health benefits as type 2 diabetics do when taking the antidiabetic drug metformin. The recent study showed that early benefits from taking the drug disappeared later on in the study.
Life December 4, 2015
Metformin, one of the leading drugs used for diabetes, is set to be launched as an anti-aging pill in 2016 as its first clinical trial on humans received a green light from the U.S. Food and Drug Administration. This could pave the way for longevity among humans.
Life December 1, 2015
Metformin, a drug commonly used to treat diabetes, is slated to undergo a clinical trial as a drug that targets fundamental biological processes involved in aging. The study is not aimed at achieving immortality, but it is about aging less like a flower and more like a fine wine.
Feature August 26, 2015
New research suggests that the drug Metformin, which is commonly prescribed for patients with Type 2 diabetes, is associated with increased risks for low levels of thyroid-stimulating hormone for those with underactive thyroid.
Life September 23, 2014